PH21847A - Phenalkoxyalkyl-and phenoxyalkyl-substituted oxiranecarboxylic acids,their use and medicaments containing them - Google Patents

Phenalkoxyalkyl-and phenoxyalkyl-substituted oxiranecarboxylic acids,their use and medicaments containing them

Info

Publication number
PH21847A
PH21847A PH26072A PH26072A PH21847A PH 21847 A PH21847 A PH 21847A PH 26072 A PH26072 A PH 26072A PH 26072 A PH26072 A PH 26072A PH 21847 A PH21847 A PH 21847A
Authority
PH
Philippines
Prior art keywords
phenalkoxyalkyl
phenoxyalkyl
medicaments containing
oxiranecarboxylic acids
substituted oxiranecarboxylic
Prior art date
Application number
PH26072A
Other languages
English (en)
Inventor
Klaus Eistetter
Erich Rapp
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of PH21847A publication Critical patent/PH21847A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/147—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of carboxylic acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/36—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/17—Unsaturated ethers containing halogen
    • C07C43/174—Unsaturated ethers containing halogen containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/178—Unsaturated ethers containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/225—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/257—Ethers having an ether-oxygen atom bound to carbon atoms both belonging to six-membered aromatic rings
    • C07C43/29—Ethers having an ether-oxygen atom bound to carbon atoms both belonging to six-membered aromatic rings containing halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PH26072A 1980-08-25 1981-08-20 Phenalkoxyalkyl-and phenoxyalkyl-substituted oxiranecarboxylic acids,their use and medicaments containing them PH21847A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH639780 1980-08-25
CH152681 1981-03-06

Publications (1)

Publication Number Publication Date
PH21847A true PH21847A (en) 1988-03-17

Family

ID=25687902

Family Applications (1)

Application Number Title Priority Date Filing Date
PH26072A PH21847A (en) 1980-08-25 1981-08-20 Phenalkoxyalkyl-and phenoxyalkyl-substituted oxiranecarboxylic acids,their use and medicaments containing them

Country Status (16)

Country Link
US (1) US4337267A (fr)
EP (1) EP0046590B1 (fr)
JP (1) JPS6059914B2 (fr)
AU (1) AU549447B2 (fr)
CA (1) CA1167050A (fr)
DE (1) DE3170608D1 (fr)
DK (1) DK171890B1 (fr)
ES (1) ES8300730A1 (fr)
GR (1) GR75741B (fr)
IE (1) IE51534B1 (fr)
IL (1) IL63627A (fr)
NZ (1) NZ198136A (fr)
PH (1) PH21847A (fr)
PT (1) PT73563B (fr)
WO (1) WO1982000643A1 (fr)
YU (1) YU206681A (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2556496B2 (ja) * 1985-08-02 1996-11-20 ホルスト パウル オットー ヴォルフ 高脂血症の治療のための薬剤
EP0283168A3 (fr) * 1987-03-16 1989-06-14 American Home Products Corporation Carboxylates de fluoroxiranne
US4788304A (en) * 1987-12-07 1988-11-29 American Home Products Corporation Phospholipase A2 inhibitors
DE3906953A1 (de) * 1989-03-04 1990-09-20 Byk Gulden Lomberg Chem Fab Verfahren zur herstellung optisch reiner oxirancarbonsaeuren
US5545672A (en) * 1993-02-11 1996-08-13 The University Of Texas System Treatment of insulin resistance and type 2 diabetes mellitus with a thiol protease inhibitor
IS4164A (is) * 1993-06-11 1994-12-12 Ab Astra Efnasambönd sem hindra flæði magasýru
US5556863A (en) * 1993-06-11 1996-09-17 Astra Aktiebolag Compound for gastric acid secretion inhibition
US6013666A (en) * 1996-07-02 2000-01-11 Sang Sup Jew Oxirane carboxylic acid derivative and its manufacturing method
KR19980028082A (ko) * 1996-10-21 1998-07-15 김박광 혈당 강하 작용을 갖는 신규 옥시란 카복실산의 유도체, 그 제조방법 및 이를 함유하는 당뇨병 치료제
DE19705718A1 (de) 1997-02-14 1998-08-20 Horst P O Dr Wolf Neue Oxirancarbonsäuren zur Behandlung des Diabetes Typ 2 und anderer insulinresistenter Zustände
US5932763A (en) * 1997-05-15 1999-08-03 Bayer Corporation Inhibition of matrix metalloproteases by 2-(ω-arolalkyl)-4-biaryl-4-oxobutyric acids
DE10115938A1 (de) 2001-03-30 2002-10-10 Medigene Ag Ges Fuer Molekular Verfahren zur Herstellung von Oxirancarbonsäuren und Derivaten davon
CA2460782C (fr) * 2001-09-26 2011-11-08 Emisphere Technologies, Inc. Procede de preparation des acides phenoxy alcanoique, alcenoique et alkynoique et de leurs sels au moyen d'un intermediaire dicarboxylate
EP1594439A2 (fr) * 2003-02-13 2005-11-16 Albert Einstein College Of Medicine Of Yeshiva University Regulation de la prise alimentaire et de la production de glucose par modulation des niveaux d'acyl-coa gras de chaine longue dans l'hypothalamus
WO2006041922A2 (fr) * 2004-10-08 2006-04-20 Dara Biosciences, Inc. Agents, et procedes d'administration au systeme nerveux central
US20070026079A1 (en) * 2005-02-14 2007-02-01 Louis Herlands Intranasal administration of modulators of hypothalamic ATP-sensitive potassium channels
CA2766282C (fr) 2008-06-27 2021-03-02 Meta-Iq Aps Inhibiteurs de la carnitine palmitoyltransferase-1 pour le traitement et la prevention de troubles provoques par une delipidation du tissu nerveux
AU2016279486B2 (en) 2015-06-15 2021-04-01 Nmd Pharma A/S Compounds for use in treating neuromuscular disorders
US11591284B2 (en) 2017-12-14 2023-02-28 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US10385028B2 (en) 2017-12-14 2019-08-20 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US11147788B2 (en) 2017-12-14 2021-10-19 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US11730714B2 (en) 2017-12-14 2023-08-22 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1551078A (en) * 1975-09-22 1979-08-22 Mcneilab Inc Alkyl-substituted glycidates and thioglycidates
US4196300A (en) * 1975-09-22 1980-04-01 Mcneilabs, Inc. α-Alkyl-substituted glycidates and thioglycidates
US4132720A (en) * 1978-04-20 1979-01-02 Mcneil Laboratories, Inc. Alkenylglycidic acid derivatives
US4132719A (en) * 1978-04-20 1979-01-02 Mcneilab Inc. Dibromoalkylglycidic acid derivatives
ATE3291T1 (de) * 1979-09-07 1983-05-15 Byk Gulden Lomberg Chemische Fabrik Gmbh Substituierte oxirancarbonsaeuren, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende arzneimittel.

Also Published As

Publication number Publication date
IL63627A (en) 1984-11-30
GR75741B (fr) 1984-08-02
AU7447581A (en) 1982-03-04
EP0046590A2 (fr) 1982-03-03
IE51534B1 (en) 1987-01-07
DK183882A (da) 1982-04-23
DK171890B1 (da) 1997-08-04
EP0046590B1 (fr) 1985-05-22
JPS6059914B2 (ja) 1985-12-27
AU549447B2 (en) 1986-01-30
ES504922A0 (es) 1982-11-16
IL63627A0 (en) 1981-11-30
JPS57501233A (fr) 1982-07-15
PT73563A (en) 1981-09-01
ES8300730A1 (es) 1982-11-16
WO1982000643A1 (fr) 1982-03-04
YU206681A (en) 1983-10-31
CA1167050A (fr) 1984-05-08
PT73563B (en) 1983-07-14
US4337267A (en) 1982-06-29
IE811931L (en) 1982-02-25
DE3170608D1 (en) 1985-06-27
NZ198136A (en) 1983-12-16
EP0046590A3 (en) 1982-04-07

Similar Documents

Publication Publication Date Title
PH21850A (en) Dialkoxypyridines,their use and medicaments containing them
DE3175083D1 (en) Pharmaceutical compounds, their preparation and use
DE3368610D1 (en) Phenyl-1-piperidino-2-propanol derivatives, their preparation and medicaments containing them
DE3171325D1 (en) Tridecyloxy- or tetradecyloxy-propane derivatives, and their use
IL63880A0 (en) Medicament containing 2-amino-6-trifluoromethoxy-benzothiazole
JPS5791921A (en) Medicine and manufacture
KE3545A (en) 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridine-3-carboxylic acids,processes for their preparation and medicaments containing these compounds
PH21847A (en) Phenalkoxyalkyl-and phenoxyalkyl-substituted oxiranecarboxylic acids,their use and medicaments containing them
JPS5750913A (en) Nifedipin-containing solid medicine and manufacture
JPS5753473A (en) Novel n-aryl-2-oxazolidinones, manufacture and drug containing them
JPS5718624A (en) Drug and manufacture
JPS5756478A (en) Triazinylaminotriazines, manufacture and use
DE3168902D1 (en) Epoxy-cycloalkylalkanecarboxylic acids, process for their preparation, their use and medicaments containing them
DE2960024D1 (en) Substituted diphenylmethyl-imidazoles, their preparation and medicaments containing them
JPS56139420A (en) Drug
JPS56150012A (en) Isotomic solution medicine
JPS56164191A (en) Theophyllinylmethyldioxolane derivative, its manufacture and medicine
JPS57123190A (en) Novel esters, manufacture and medicine containing same
JPS57118521A (en) Blood products and manufacture
JPS5748993A (en) N-phosphonylcarbonyl-carbamates, manufacture and use
ZA805390B (en) Substituted quinolinone-alkanecarboxylic acids, their preparation and use, and medicaments containing them
PH16940A (en) Substituted phenoxy-aminopropanol derivatives and medicaments thereof
ZA811567B (en) 2-penem-3-carboxylic acid derivatives, their preparation and use
DE3167536D1 (en) 3-chloroquinoline derivatives, processes for their preparation and medicaments containing them
JPS57106613A (en) Pharmacetical medicine